HMN 2025: The first new non-opioid painter approved in the United States for these years how it works

A new non-opioid painkiller, SuzatrigineIt is just approved by US drug controller, the FDA. This is the first non-opioid painter approved by the Agency for over twenty years.

Due to its addictive nature, many medical professionals have done in recent years minimize the use of opioidsEspecially the length of time taken for the following surgery. Patients who were getting opioids for longer than a week were found to double surgery on their risk of using these drugs for more than a year.

In the US, A study showed About 6% of all patients who went under surgery were continuous opioid users, even if they never did opioids before. Therefore, it is great to find a relatively safe and effective non-opioid drugs to treat sharp pain without the risk of addiction.

Suzetrigine works by blocking the activity of proteins called sodium routes in nervous cells that send pain symptoms. This stops the pain sign in its tracks, before it reaches your brain and thus before you experience it.

This is exactly how local anesthetic drugs, such as lidocaine, work. Unfortunately, these drugs inhibit all sodium channels throughout your body, including those that control your heart, brain and breathe activity. That is why, as the name suggests, they can only be applied locally.

In dentistry, this is usually used using a syringe and attached to another drug (called “vasoconstrictor”) to stop the anesthetic from escaping into the bloodstream.

It is a great idea in principle to focus on sodium ways to relieve pain. However, it is affected by the widespread presence of these proteins – which initiates electrical signage in almost all cells of your body – and the risks associated with obstructing them. At least the real risk of sudden death.

In Japan, Fugu is an alien delicacy, a dish made from puffer fish. It is part of his attraction at least the little tingle in the tongue that can be in it. This tendency is a poison, Tetrodotoxin, which is a strong barrier to sodium routes. Too much tetrodotoxin is fatal. In Japanese restaurants, only qualified fugu handlers are allowed to prepare the dish.

So why is discovery and development of suzetrigine so important? We have nine different types that make a code for sodium routes (they run from nav1.1 to nav1.9). Each of these routes is present at different levels in different cells and organs of your body. But only one of these routes, NAV1.8, is present in peripheral pain detection and not in other parts of the body.

There is no evidence of nav1.8 expression in your heart or in your brain. This optional expression suggests that this particular sodium channel could be a good goal to relieve pain.

This idea found further credit after the discovery that people with genetic mutations that increase this channel’s activity suffered nervous pain Despite the fact that there is no clear reason for the pain.

The preference

In recent years, Vertex Pharmaceuticals, the company makes Suzetrigine (brand name magazine name), many potential drugs to try a safe, optional barrier of these ways that could be done orally. Both suzetrigine were found to a strong backer and the -chosen of these ways. It is, impressive, at least 30,000 times stronger by blocking nav1.8 routes than the other types of sodium routes we have.

In two clinical trials With more than 1,000 patients in each, it was found that suzetrigine was as effective as opioids by blocking sharp pain after moderate painful-bain surgery to remove bunions or belly-tuck.

Suzetrigine produced much less side effects than opioid treatment and there was no risk of addiction. So far, however, there is no convincing evidence that suzetrigine is effective in relieving chronic, long -term pain.

The discovery and approval to use suzetrigine opens the possibility of treating acute pain by selectively blocking specific sodium routes, without the risk of addiction. In general, Optional focus on the many different ion channels This basis of pain signage can solve the way for new, non-thunder treatments for all types of sharp and chronic pain.